Lawrence V. Gulotta

Lawrence V. Gulotta

Auto-generated profile, based on publicly available information

Lawrence V. Gulotta

Hospital for Special Surgery, New York, NY

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2009 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
LGLawrence V. Gulotta
Lawrence V. Gulotta
DKDavid Kovacevic
David Kovacevic
JEJohn R. Ehteshami
John R. Ehteshami
EDElias Dagher
Elias Dagher
JPJonathan D. Packer
Jonathan D. Packer
SRScott A. Rodeo
Scott A. Rodeo
Background: Rotator cuff tendons heal to bone with interposed scar tissue, which makes repairs prone to failure. The purpose of this study was to determine if the application of bone marrow-derived mesenchymal stem cells (MSCs) can improve rotator cuff healing after repair. Hypothesis: Application of MSCs to the repair site will result in superior results compared with controls on histologic and biomechanical testing. Study Design: Controlled laboratory study. Methods: Ninety-eight Lewis rats underwent unilateral detachment and repair of the supraspinatus tendon; 10 rats were used for MSC harvest. Eight animals were used for cell tracking with Ad-LacZ. The remaining animals received either 10 6 MSCs in a fibrin carrier, the carrier alone, or nothing at the repair site. Animals were sacrificed at 2 and 4 weeks for histologic analysis to determine the amount of fibrocartilage formation and the collagen organization at the insertion. Biomechanical testing was also performed. Results: Specimens treated with Ad-LacZ–transduced MSCs exhibited more β-galactosidase activity at the repair site compared with controls at both 2 and 4 weeks, although activity at 4 weeks was less than that at 2 weeks. There were no differences in the amount of new cartilage formation or collagen fiber organization between groups at either time point. There were also no differences in the biomechanical strength of the repairs, the cross-sectional area, peak stress to failure, or stiffness. Conclusion: The addition of MSCs to the healing rotator cuff insertion site did not improve the structure, composition, or strength of the healing tendon attachment site despite evidence that they are present and metabolically active. Clinical Relevance: A biologic solution to the problem of tendon-to-bone healing in the rotator cuff remains elusive. The repair site may lack the cellular and/or molecular signals necessary to induce appropriate differentiation of transplanted cells. Further studies are needed to determine if cell-based strategies need to be combined with growth and differentiation factors to be effective.

18 February 2011 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
LGLawrence V. Gulotta
Lawrence V. Gulotta
DKDavid Kovacevic
David Kovacevic
JPJonathan D. Packer
Jonathan D. Packer
XDXiang Hua Deng
Xiang Hua Deng
SRScott A. Rodeo
Scott A. Rodeo
Background: Rotator cuffs heal through a scar tissue interface after repair that makes them prone to failure. Scleraxis (Scx) is a basic helix-loop-helix transcription factor that is thought to direct tendon development during embryogenesis. The purpose of this study was to determine if the application of mesenchymal stem cells (MSCs) transduced with adenoviral-mediated scleraxis (Ad-Scx) could improve regeneration of the tendon-bone insertion site in a rat rotator cuff repair model. Hypothesis: Bone marrow–derived cells transduced with Scx would improve the structure of the healing tendon-bone interface and result in increased tendon attachment strength. Study Design: Controlled laboratory study. Methods: Sixty Lewis rats underwent unilateral detachment and repair of the supraspinatus tendon. Thirty animals received MSCs in a fibrin glue carrier, and 30 received Ad-Scx-transduced MSCs. Animals were sacrificed at 2 weeks and 4 weeks and evaluated for the presence of fibrocartilage and collagen fiber organization at the insertion. Biomechanical testing was performed to determine the structural and material properties of the repaired tissue. Statistical analysis was performed with a Wilcoxon rank sum test with significance set at P = .05. Results: There were no differences between the Scx and MSC groups in terms of histologic appearance at 2 weeks. However, the Scx group had higher ultimate stress-to-failure (2.6 ± 0.9 vs 1.7 ± 0.3 MPa; P = .03) and stiffness (8.4 ± 2.9 vs 5.0 ± 1.9 N/mm; P = .01) compared with the MSC group. At 4 weeks, the Scx group had more fibrocartilage (728.7 ± 50.4 vs 342.6 ± 217.0 mm 2 ; P = .04), higher ultimate load to failure (26.7 ± 4.6 vs 20.8 ± 4.4 N; P = .01), higher ultimate stress to failure (4.7 ± 1.3 vs 3.5 ± 1.0 MPa; P < .04), and higher stiffness values (15.3 ± 3.4 vs 9.3 ± 2.2 N/mm; P < .001) as compared with the MSC group. Conclusion: Mesenchymal stem cells genetically modified with Scx can augment rotator cuff healing at early time points. Clinical Relevance: Biologic augmentation of acutely injured rotator cuffs with Scx-transduced MSCs may improve rotator cuff tendon healing and reduce the incidence of re-tears. However, further studies are needed to determine if this remains safe and effective in larger models.

16 April 2010 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
LGLawrence V. Gulotta
Lawrence V. Gulotta
DKDavid Kovacevic
David Kovacevic
SMScott Montgomery
Scott Montgomery
JEJohn R. Ehteshami
John R. Ehteshami
JPJonathon D. Packer
Jonathon D. Packer
SRScott A. Rodeo
Scott A. Rodeo
Background: Rotator cuffs heal through a scar tissue interface after repair, which makes them prone to failure. Membrane type 1 matrix metalloproteinase (MT1-MMP) is upregulated during embryogenesis in areas that develop into tendon-bone insertion sites.

1 September 2012 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
LGLawrence V. Gulotta
Lawrence V. Gulotta
DCDan Choi
Dan Choi
PMPatrick Marinello
Patrick Marinello
ZKZakary Knutson
Zakary Knutson
JLJoseph Lipman
Joseph Lipman
RWRussell F. Warren
Russell F. Warren

1 September 2011 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
LGLawrence V. Gulotta
Lawrence V. Gulotta
SNShane J. Nho
Shane J. Nho
CDChristopher C. Dodson
Christopher C. Dodson
RARonald S. Adler
Ronald S. Adler
DADavid W. Altchek
David W. Altchek
JMJohn D. MacGillivray
John D. MacGillivray

3 May 2011 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
SJScott A Jelinsky
Scott A Jelinsky
SRScott A. Rodeo
Scott A. Rodeo
JLJian Li
Jian Li
LGLawrence V Gulotta
Lawrence V Gulotta
JAJoanne M Archambault
Joanne M Archambault
HSHoward J Seeherman
Howard J Seeherman
Chronic tendon injuries, also known as tendinopathies, are common among professional and recreational athletes. These injuries result in a significant amount of morbidity and health care expenditure, yet little is known about the molecular mechanisms leading to tendinopathy.